These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5412542)

  • 1. Measurement of plasma estradiol-17beta by competitive binding assay employing pregnancy plasma.
    Dufau ML; Dulmanis A; Catt KJ; Hudson B
    J Clin Endocrinol Metab; 1970 Mar; 30(3):351-6. PubMed ID: 5412542
    [No Abstract]   [Full Text] [Related]  

  • 2. [1st results with the ethynodiol diacetate-mestranol combination].
    Mancuso S
    Minerva Ginecol; 1966 Apr; 18(8):433-7. PubMed ID: 5920234
    [No Abstract]   [Full Text] [Related]  

  • 3. [Indications and treatment of menstrual disorders with a synthetic progestational hormone, ethynodiol diacetate alone or combined in variable doses with an estrogen].
    Soutoul JH
    Rev Fr Gynecol Obstet; 1969; 64(1):41-55. PubMed ID: 5362109
    [No Abstract]   [Full Text] [Related]  

  • 4. The problem of period control in disabled women.
    Hamilton EA; Nichols PJ
    Ann Phys Med; 1968 Aug; 9(7):288-94. PubMed ID: 4234086
    [No Abstract]   [Full Text] [Related]  

  • 5. A radio-ligand binding assay system for estradiol measurement in human plasma.
    Korenman SG; Perrin LE; McCallum TP
    J Clin Endocrinol Metab; 1969 Jul; 29(7):879-83. PubMed ID: 5793447
    [No Abstract]   [Full Text] [Related]  

  • 6. Measurement of estradiol-17 beta in plasma by competitive protein-binding radioassay.
    Shutt DA
    Steroids; 1969 Jan; 13(1):69-82. PubMed ID: 4884858
    [No Abstract]   [Full Text] [Related]  

  • 7. [The treatment of meno-metrorrhagia of functional origin by an estro-progestational compound: ethynodiol diacetate combined with mestranol].
    Dumont M; Thoulon JM
    Lyon Med; 1967 Jun; 217(25):1847-52. PubMed ID: 5610232
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ovulen in the treatment of the premenstrual syndromes in psychiatric patients].
    Rasmussen R; Hagen A; Ravn J
    Ugeskr Laeger; 1967 Feb; 129(7):224-6. PubMed ID: 5599219
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of synthetic steroid preparations for hemostasis and normalization of menstrual function in juvenile hemorrhages].
    Kuznetsova MN; Antipina NN; Zagorskaia EA
    Vopr Okhr Materin Det; 1978 Feb; 23(2):77-80. PubMed ID: 347706
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurement of unconjugated 17 -estradiol in plasma by competitive protein binding.
    Knox BS; France JT
    Clin Chem; 1972 Mar; 18(3):212-6. PubMed ID: 5020816
    [No Abstract]   [Full Text] [Related]  

  • 11. Estimation of oestrone sulphate, oestradiol-17beta and oestrone in peripheral plasma: concentrations during the menstrual cycle and in men.
    Hawkins RA; Oakey RE
    J Endocrinol; 1974 Jan; 60(1):3-17. PubMed ID: 4812465
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience with an estrogen-progestogen association with low estrogen content (ethinodiol-ethinylestradiol)].
    Andreoli C; Fiorentino F; Lenzi G
    Quad Clin Ostet Ginecol; 1970 Jan; 25(1):15-28. PubMed ID: 5523807
    [No Abstract]   [Full Text] [Related]  

  • 13. [Induction of uterine hemorrhage using 17-alpha-ethynyl-4-estrene-3-beta, 17-beta-diol diacetate (ethynodiol diacetate)].
    Tanaka Y
    Sanfujinka No Jissai; 1969 Feb; 18(2):185-7. PubMed ID: 5818867
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytologic and colposcopic findings before and after administration of ovulation inhibitors].
    Loskant G; Heinen G
    Zentralbl Gynakol; 1968 May; 90(18):609-13. PubMed ID: 5722983
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ovulen, its effect on the endometrium, uterine cervix and ovary].
    Muller G; Dehalleux JM; Ritter J; Philippe E; Gandar R
    Gynecol Obstet (Paris); 1968; 67(5):521-32. PubMed ID: 5730661
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat.
    Butcher RL; Collins WE; Fugo NW
    Endocrinology; 1974 Jun; 94(6):1704-8. PubMed ID: 4857496
    [No Abstract]   [Full Text] [Related]  

  • 17. Radioimmunoassay of estrone and estradiol-17 in peripheral plasma of pregnant and non-pregnant women.
    de Hertogh R
    J Steroid Biochem; 1973 Jan; 4(1):75-84. PubMed ID: 4705028
    [No Abstract]   [Full Text] [Related]  

  • 18. [FH 027 in the treatment of dysmenorrhea].
    Kolenc M
    Bord Med; 1970 May; 3(5):1409-10. PubMed ID: 5425890
    [No Abstract]   [Full Text] [Related]  

  • 19. Concentrations of unconjugated estrone, estradiol, androstenedione and testosterone in ovarian and peripheral venous plasma in women: the effects of steroid contraceptives.
    Weisz J; Lloyd CW; Lobotsky J; Pupkin M; Zanartu J; Puga J
    J Clin Endocrinol Metab; 1973 Aug; 37(2):254-60. PubMed ID: 4720072
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormonal treatment of impetigo herpetiformis.
    Gligora M; Kolacio Z
    Br J Dermatol; 1982 Aug; 107(2):253. PubMed ID: 7104221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.